Electronic cigarettes: A short review

Respiration

Volumn 86, Issue 5, 2013, Pages 433-438

  Bertholon, J F ^a,b,e   Becquemin, M H ^a,c   Annesi Maesano, I ^d,e   Dautzenberg, B ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

^e Unite Mixte de Recherche en Sante 952   (France)

Author keywords

Electronic cigarettes; Nicotine; Propylene glycol

Indexed keywords

ELECTRONIC CIGARETTE; GLYCEROL; NICOTINE; PROPYLENE GLYCOL; DRUG ADDITIVE;

AEROSOL; CONTAMINATION; DRUG DELIVERY SYSTEM; ENVIRONMENTAL EXPOSURE; FLAVOR; GENERATOR; HUMAN; INTOXICATION; METERED DOSE INHALER; NEBULIZER; NONHUMAN; PASSIVE SMOKING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; TEMPERATURE; TOXICITY; VAPORIZATION; CHRONIC TOXICITY; DRUG CONTAMINATION; HEALTH IMPACT ASSESSMENT; LONG TERM EXPOSURE; SMOKING; TOBACCO DEPENDENCE;

AEROSOLS; ELECTRICAL EQUIPMENT AND SUPPLIES; HUMANS; NEBULIZERS AND VAPORIZERS; NICOTINE; NICOTINIC AGONISTS; PROPYLENE GLYCOL; SMOKING; SMOKING CESSATION;

EID: 84894274032     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000353253     Document Type: Review

References (36)

1. Westenberger BJ: Evaluation of e-cigarettes. Rockville, FDA Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis, 2009.
2. Trtchounian A, Williams M, Talbot P: Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res 2010; 12: 905-912.
3. Bertholon JF, Becquemin MH, Roy M, Roy F, Ledur D, Annesi Maesano I, Dautzenberg B: Comparaison de l'aerosol de la cigarette electronique a celui des cigarettes ordinaires et de la chicha. Rev Mal Respir, in press.
4. Becquemin MH, Bertholon JF, Attoui M, Roy F, Roy M, Dautzenberg B: Tailles particulaires de la fumee produite par six differents types de cigarettes. Rev Mal Respir 2007; 24: 845- 852. (Pubitemid 47441069)
5. Pellegrino RM, Tinghino B, Mangiaracina G, Marani A, Vitali M, Protano C, Osborn JF, Cattaruzza MS: Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig 2012; 24: 279- 288.
6. Schripp T, Markewitz D, Uhde E, Salthammer T: Does e-cigarette consumption cause passive vaping? Indoor Air 2013; 23: 25-31.
7. Ingebrethsen BJ, Cole SK, Alderman SL: Electronic cigarette aerosol particle size distribution measurements. Inhal Toxicol 2012; 24: 976-984.
8. Werley MS, McDonald P, Lilly P, Kirkpatrick D, Wallery J, Byron P, Venitz J: Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs. Toxicology 2011; 287:76-90.
9. McAuley TR, Hopke PK, Zhao J, Babaian S: Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol 2012; 4: 850-857.
10. Montharu J, Le Guellec S, Kittel B, Rabemampianina Y, Guillemain J, Gauthier F, Diot P, de Monte M: Evaluation of lung tolerance of ethanol, propylene glycol, and sorbitan monooleate as solvents in medical aerosols. J Aerosol Med Pulm Drug Deliv 2010; 23: 41-46.
11. UNEP: OECD SIDS Initial Assessment Report 2001: Propylene glycol. www.chem. unep.ch/irptc/sids/OECDSIDS/sidspub.html
12. Janusz Szajewski MD: Warsaw Poison Control Centre 1991: Propylene glycol (PIM 443). IPCS INChem, 2009.
13. Fiches Internationales de Sécurité Chimique: Propylène glycol. http://www.cdc.gov/niosh/ ipcsnfrn/nfrn0321.html
14. Burr GA, Van Gilder TJ, Trout DB, Wilcox TG, Driscoll R: NIOSH Health Hazard Evaluation HETA 90-0355-2499. Actor's Equity Association, 1994.
15. HSE Consulting and Sampling, Inc.: Literature Review for Glycerol and Glycols.pdf. for Entertainment Services & Technology Association. http://casaa.org/uploads/LiteratureReviewforGlycerolandGlycols.pdf
16. Moline JM, Golden AL, Highland JH, Wilmarth KR, Kao AS: Health Effects Evaluation of Theatrical Smoke, Haze and Pyrotechnics. Prepared for Actor's Equity Pension and Health Trust Funds, June 6, 2000.
17. Varughese S, Teschke K, Brauer M, Chow Y, van Netten C, Kennedy SM: Effects of theatrical smokes and mists on respiratory health in the entertainment industry. Am J Ind Med 2005; 47: 411-418. (Pubitemid 40632371)
18. ANSI E1.5 Entertainment Technology: Theatrical fog made with aqueous solutions of diand trihydric alcohols F&S/1997-3017r7, 2003.
19. Raymond GE, Cohen JM: Recommended Exposure Guidelines for Glycol Fogging Agents. Project No. 6070-1001, 1997.
20. Cate JC IV, Hedrick R: Propylene glycol intoxication and lactic acidosis. N Engl J Med 1980; 303: 1237. (Pubitemid 11207593)
21. Arulanantham K, Genel M: Central nervous system toxicity associated with ingestion of propylene glycol. J Pediatr 1978; 93: 515-516. (Pubitemid 8384118)
22. Lessman H, Schnuch A,Geier J, Uter W: Skinsensitizing and irritant properties of propylene glycol. Contact Dermatitis 200; 553: 247-259.
23. Cone JE, Shusterman D: Health effects of indoor odorants. Environ Health Perspect 1991; 95: 53-59.
24. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P: Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012; 4: 529- 537.
25. Cheah NP, Chong NW, Tan J, Morsed FA, Yee SK: Electronic nicotine delivery systems: regulatory and safety challenges: Singapore perspective. Tob Control 2012, E-pub ahead of print.
26. Cahn Z Siegel M Electronic cigarettes as a Harm Reduction Strategy For Tobacco Control A Step Forward Or A Repeat Of Past Mistakes? J Public Health Policy 2011; 32 16-31.
27. Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger B: Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A 2010; 48: 7547-7555.
28. Gennimata SA, Palamidas A, Kaltsakas G, Tsikrika S, Vakali S, Gratziou C, Koulouris N: Acute effects of e-cigarette on pulmonary function in healthy subjects and smokers. ERS Congress, Vienna, 2012.
29. Vakali S, Tsikrika S, Gennimata SA, Kaltsakas G, Palamidas A, Koulouris N, Gratziou C: Acute impact of a single e-cigarette smoking on symptoms, vital signs and airways inflammatory response. ERS Congress, Vienna, 2012.
30. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK: Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012; 141: 1400-1406.
31. Farsalinos K, Tsiapras D, Kyzopoulos S, Savvopoulos M, Avramidou E, Vassilopoulou D, Voudris V: Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function: comparison with the effects of regular cigarettes. http://www.escardio. org/about/press/esc- congress-2012/ press-conferences/Documents/presentations/ konstantinos- farsalinos.pdf
32. Kuschner WG, Reddy S, Mehrotra N, Paintal HS: Electronic cigarettes and third-hand tobacco smoke: two emerging health care challenges for the primary care provider. Int J Gen Med 2011; 4: 115-120.
33. ERS statement on e-cigarettes 2012. http:// www.ersnet.org/news/item/ 4494-europeanrespiratory- society-statement-on-e-cigarettes- and-emerging-products-.html
34. Bullen C, McRobbie H, Thornley S, Lin M, Laugesen M: Effect of an electronic nicotine delivery device (e-cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control 2010; 19: 98-103.
35. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C: Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011; 11: 786.
36. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Russo C, Polosa R: The efficacy and safety of an electronic cigarette (ECLAT) study: a prospective 12-month randomized control design study. XIV SRNT Europe Conference Helsinki, Finland, 2012.